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COMPLICATED PEPTIC ULCER TREATED BY 
COBALT-60* TELETHERAPY 
A Preliminary Report of Results in 34 Patients 
CHARLES H . BROWN, M.D.** 
During the last three years, cobalt-60 teletherapy has been used at the Cleveland 
Chnic in conjunction with intensive medical treatment in 34 patients having com-
plicated peptic ulcer. Since a long-term follow-up always is necessary to evaluate 
properly any new type of therapy for peptic ulcer, this paper is only a preliminary report. 
The use of irradiation in the treatment of peptic ulcer is not new, and various 
technics have been employed to deliver the irradiation to the stomach itself. Previously, 
we have treated a few patients with a 250-kv. roentgen ray machine. Irradiation by 
means of cobalt-60 teletherapy unit\ as we have used it, has been an adjunct to 
conventional therapy^ and has not replaced diet, sedation, antacids, and anticholinergic 
drugs. 
The goal of irradiation of the stomach is to decrease acid secretion. Numerous 
studies have shown that roentgen irradiation at least temporarily decreases gastric 
acid secretion and frequently results in anacidity^ Roentgen therapy for peptic ulcer 
was first used by Bruegel'' in 1917 and since has been used by a number of workers. 
Palmer, Kirsner, and their group at The University of Chicago have employed this 
form of therapy more extensively than any other group". Levin, Clayman, and 
Palmer' reported the results in 723 patients treated from 1937 to 1950 and followed 
to January of 1956. The recurrence rate of symptoms per 100 patients' years was 
102 before treatment and was 17 after treatment. The recurrence rate of hemorrhage 
was reduced from 4.3 before to 1.1 patient years after treatment and perforation 
from 0.2 before to 0.1 after treatment. They noted no serious side effects of irradiation. 
Some patients had erythema of the skin and subsequent tanning, but none developed 
leukemia. Their study with its long follow-up indicates that the results from the 
combined use of irradiation and rather strict medical treatment are excellent. 
Various technics of irradiation have been used. McGeorge' has placed radium 
needles in the stomach. Brown and associates'", in England, combined irradiation 
with antroduodenectomy. Palmer's technic' has been to administer 1800 to 2500 
roentgen units to the fundus of the stomach through two portals with a 250-kv. 
machine. The stomach is outlined fluoroscopically before therapy is started. Con-
ventional medical therapy also is given to these patients. 
It has been repeatedly stressed "No acid, no ulcer." Any therapy that resuhs 
in anacidity will be effective ulcer treatment, and even treatment that causes a 
*The radioactive material used in this study was supplied on authorization of the Isotopes Division, 
United States Atomic Energy Commission, Oak Ridge, Tennessee. 
**From the Department of Gastroenterology, The Cleveland Clinic Foundation, and The Frank E. 
Bunts Educational Institute, Cleveland, Ohio. 
This study was done with the help and co-operation of Robert A. Hays, M.D., Department of 
Radiology, The Cleveland Clinic Foundation, 
Given in part before the Henry Ford Hospital Medical Association, May 31, 1957, Detroit, Mich. 
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reduction in acidity may be effective. Previous studies have shown; 
1. Irradiation depresses gastric secretion. 
2. There is a correlation between the degree of reduction of anacidity and the 
amount of irradiation given. 
3. The decrease in acid secretion may persist for varying periods of time. In 
a few patients the depression of gastric acid secretion may be permanent but 
in most patients it is only temporary. 
4. While the acid secretion is depressed, particularly if anacidity occurs, the 
ulcer heals; and the ulcer does not recur until and unless the acid secretion 
returns. 
The technic of irradiation employed in our patients was adapted from that of 
Palmer,'-' except that the cobalt unit was used instead of the roentgen ray machine. 
While most of Palmer's patients were hospitalized, ours were treated as out-patients. 
The stomach was outlined by barium fluoroscopically and marked on the skin an-
teriorly and posteriorly in two fields. These two fields were centered over the upper 
two thirds of the stomach and were employed for the irradiation. It should be 
noted that the irradiation is given to the upper two thirds of the stomach, which is 
the acid-secreting portion, and not to the ulcer itself. Each patients received a total 
of approximately 2000 roentgen units (depth dose). 
The cobalt-60 teletherapy unit has certain physical advantages over the conven-
tional roentgen ray machine. In particular, it has a skin-sparing effect and, being 
more penetrating, a greater depth dose is obtained. We believe that there is no 
difference between the biologic reaction to the gamma rays of cobalt-60 and the 
reaction to the roentgen rays of the 250-kv. roentgen ray machine. 
In addition to irradiation the patients were treated medically' on an intensive 
ulcer program. This consisted of a liberal diet, but with food or milk every two 
hours on the even hours, antacids on the odd hours, mild sedation and anticholinergic 
drugs. 
SELECTION OF PATIENTS 
The 34 patents selected for cobalt-60 teletherapy had not responded to previous 
medical treatment, had evidence of complications or intractability of ulcer and were 
considered possible candidates for operation. Several had severe cardiac disease 
contraindicating operation. One patient became cyanotic on the operating table before 
surgery and operation was cancelled. Cobalt-60 teletherapy was not used in patients 
having simple uncomplicated ulcers or having a first attack of peptic ulcer. 
Of our 34 patients, 28 had duodenal ulcer, four had marginal ulcer, one had 
gastric ulcer, and one had severe hyperacidity syndrome but no demonstrable ulcer. 
The average duration of ulcer distress was 11.3 years in the 28 patients having 
duodenal ulcer. Of these 28 patients, all had had repeated recurrences of ulcer, ten 
had hemorrhage, six had complications of obstruction, and one had perforation. The 
average duration of ulcer distress was 11 months in the four patients having marginal 
ulcer. Two had hemorrhage from the ulcer and all had pain. Two of the four patients 
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had had two operations each for ulcers. The patient with gastric ulcer had a 15-year 
history of previous duodenal ulcer. The patient with severe hyperacidity syndrome 
but no demonstrable ulcer, had been advised by another gastroenterologist to undergo 
gastric resection because of the severity of the symptoms. 
The average length of follow-up in patients with duodenal ulcer was six months 
(range from 2 months to 2 years). The average duration of follow-up in the other 
six patients was 11 months. This follow-up is to short for the findings to serve as a 
basis for final conclusions concerning results of treatment. With a longer follow-up 
one might expect a return of hyperacidity in more of the patients and a higher in-
cidence of recurrence of peptic ulcer and its complications. 
TOLERATION OF THERAPY 
As mentioned previously, the 34 patients were given an average depth dose of 
2000 roentgen units each, with the cobalt-60 teletherapy unit. Pretreatment and post-
treatment white cell counts and hemoglobin determinations showed no significant 
change. No skin reactions of any kind were observed in any of the patients. Six 
of the 34 patients complained of nausea and two patients vomited. Cobalt-60 tele-
therapy was better tolerated than was irradiation with a 250-kv. roentgen ray machine: 
the same dose delivered with a 250-kv. machine results in some erythema and tanning 
of the skin and in nausea and vomiting in a higher percentage of patients. 
Transient mild jaundice occurred in one patient who had severe cirrhosis with 
esophageal varices in addition to his peptic ulcer. It was possible that the irradiation 
resulted in some necrosis of liver cells and jaundice since the patient had very serious 
impairment of his liver function before irradiation. 
RESULTS 
Gastric Secretory Studies 
Gastric analysis gives us an objective measure of the effect of irradiation. The 
possible beneficial effect must be secondary to a decrease in gastric acidity. Gastric 
analyses with Histalog as a stimulant were obtained before and after irradiation. 
Histalog, which has been found to be comparable to histamine," was used as a 
stimulant to obtain a maximum gastric secretory response. 
Progress gastric secretory studies were obtained in 2 months in 30 patients. 
Gastric analyses obtained two months after cobalt-60 teletherapy showed anacidity 
in seven (23%) of the 30 patients. Eleven (37%) had a reduction in gastric acidity 
of 90% or more. Eighteen (60%) had a reduction of gastric acid secretion of 60% 
or more. It should also be noted that 18 (60%) of the patients developed a fasting 
anacidity which is seldom present in patients with duodenal ulcer. 
Six months after treatment with cobalt-60, the depression of gastric acid secretion 
was not so great. Only 1 in 15 patients had an anacidity to Histalog. Decrease in 
acidity was less marked in 8 of 15 patients as compared with that two months after 
irradiation. Consequently, with time there may be a gradual return of gastric acid 
secretion to pretreatment levels. 
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In Figure 1, the per cent change in free hydrochloric acid secretion after stimula-
tion with Histalog two months after irradiation is compared with preirradiation levels. 
Three patients had no appreciable change; nine patients had a decrease of 20 to 50%; 
and eighteen patients had a decrease of 60% or more. 
CHANGE IN FREE HCL ( H I S T A L O G ) 
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PER CENT CHANGE IN FREE HCL 
In Figure 2 are shown the concentrations of free hydrochloric acid secrefion 
before irtadiation, two months after irradiation, and six months after irradiation. In 
the top graph is a distribution before cobalt-60 therapy. Note the large number of 
patients with secretion of 90 or more units of free hydrochloric acid. The second 
curve is a distribution two months after cobalt-60 therapy. Note the marked decrease 
in acid concentration. The bottom curve shows the acid secretion six months after 
irradiation. There is a shift of the distribution to levels higher than those found 
two months postirradiation but still not so high as those found preirradiation. Despite 
that these studies show that irradiation with cobalt-60 appreciably decreases gastric 
acid secretion. Such a decrease may be temporary only, at least in some patients. 
Symptomatic Response 
It is difficult to evaluate symptomatic response of patients having peptic ulcer 
to any type of therapy. Ulcer is characterized by spontaneous remissions and exacer-
bations. Nonetheless, the long histories of ulcer in the group, the number of compli-
cations and the lack of response to previous medical, and in four cases surgical, 
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Of the 28 patients with duodenal ulcer, 27 had prompt relief of symptoms. One 
patient had recurrence of symptoms in 12 months. Another patient had an acute 
perforation in three and one-half months; however, the depression of gastric acidity 
after cobalt-60 therapy was not great in this patient. Before the perforation occurred, 
he was entirely asymptomatic and roentgen studies of the stomach showed that the 
ulcer crater had healed. At operation he was found to have a perforation of a new 
acute ulcer rather than of the old ulcer. 
AH of the patients with marginal ulcer obtained symptomatic relief after cobalt-60 
therapy, but one year after treatment one patient had a recurrence with a further 
episode of bleeding. Gastric acidity at the time of the recurrence showed that the 
hyperacidity had returned. 
The patient with gastric ulcer had prompt relief of symptoms; there has been 
no recurrence during the past 12 months. The patient with the hyperacidity syndrome 
obtained only partial relief after irradiation. 
Roentgen Response 
Initial roentgen studies of the stomach demonstrated an ulcer crater in each of 
the 28 patients with duodenal ulcer. We did not give cobalt-60 therapy unless the 
patient had a definite ulcer that was demonstrated on roentgenograms. Progress 
roentgen examinations of the stomach two months after cobalt-60 therapy were 
obtained in 24 of the 28 patients with duodenal ulcer. The ulcer crater had dis-
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appeared in all 24 of the patients, and in addition six patients who showed evidence 
of obstruction prior to cobalt-60 therapy had no evidence of obstruction on the 
progress roentgenogreims. 
In the four patients with marginal ulcer, progress roentgen studies showed the 
ulcer to have healed in three patients but to have recurred in one. 
In the patient with gastric ulcer, progress roentgenograms two months after 
cobalt-60 therapy showed that the ulcer was healed. For one year since that time, 
progress roentgen studies at three-month intervals have shown no recurrence of the 
ulcer. 
Failures in Treatment 
Failures in treatment occasionally can be more informative than successes. Since 
the purpose of cobalt-60 teletherapy is to decrease gastric acid secretion, if such a 
reduction does not occur the case must be listed as a failure. Similarly, if the gastric 
secretion returns to pre-treatment levels, the case also must be listed as a failure. 
Of the 34 patients treated with cobalt-60 teletherapy, nine must be designated 
as failing to respond satisfactorily. Of these nine failures, six remained asymptomatic 
but either had a persistence of hyperacidity by gastric analysis or had a recurrence 
of hyperacidity after an initial depression. 
Only three patients were clinical failures having recurrence of hyperacidity 
associated with recurrence of ulcer. The patient with a duodenal ulcer who developed 
an acute perforation three and one-half months after therapy already has been 
discussed. The patient with marginal ulcer who developed recurrence of pain and 
an episode of gastrointestinal bleeding one year after irradiation has been given a 
second course of cobalt-60 teletherapy and further medical treatment. Before the 
first course of teletherapy this patient had undergone two operations for peptic ulcer, 
a gastric resection for duodenal ulcer followed in six months by a vagotomy for 
marginal ulcer. The third patient who was a symptomatic failure is a patient with 
duodenal ulcer with obstruction who had recurrence of symptoms and obstruction 
one year after irradiation. Because of severe coronary heart disease, this patient was 
not operated upon but was given a second course of irradiation and continued 
medical treatment. 
Even though the follow-up period is short (average six months), the small 
number of patients (three) who were symptomatic failures is encouraging. The long 
history of ulcer in this group of patinets, the number of complications and the severity 
of the patient's distress make the good response of the remaining 31 patients more 
significant than if the patients had early uncomplicated peptic ulcer. For example, 
one of our patients had received 50 to 100 mg. of meperidine hydrochloride, three 
to four times daily, for relief of ulcer symptoms for three years prior to treatment. 
He has now been followed for ten months since irradiation with cobalt-60 and has 
not required a single injection of meperidine. A good response to treatment in such 
a patient with so-called surgical ulcer is more significant than a good response in a 




Cobalt-60 teletherapy was given to 34 patients with complicated peptic ulcer 
as a supplement to medical treatment. These patients had not previously responded 
to medical treatment and had an average duration of ulcer distress of 11.3 years. 
Therapy was well tolerated; there were minimal reactions with no skin changes 
or tanning. 
In all but three of the 34 patients, gastric acidity was decreased by cobalt-60 
therapy. There was a gradual return of acidity in some patients to pretreatment 
levels in six to twelve months. The initial symptomatic and roentgen response was 
good in all patients. There was a recurrence of symptoms, hyperacidity, and ulcer 
in three of the patients, two of whom have been given a second course of irradiation 
with cobalt-60. 
We do not advise irradiation for the simple uncomplicated peptic ulcer that 
should respond to conventional medical treatment. Irradiation with cobalt-60 may 
be indicated in many patients with complicated or "surgical" ulcer or with repeated 
recurrences of peptic ulcer. Surgical treatment may be avoided in some of these 
patients with complicated peptic ulcer by the combined use of cobalt-60 irradiation 
and intensive conventional medical therapy. 
2020 East 93 rd Street 
Cleveland, Ohio 
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